Quinn, Steve (Mainz Biomed 202201– VP of Business Development before OneOme + Progenity + Abbott Diagnostics) |
Business Development Manager / Strategy Manager |
Mainz Biomed N.V. (Nasdaq: MYNZ) |
Germany |
Quirk, Robin (Locate Therapeutics Ltd 201412 Executive Director) |
Chief Executive Officer (CEO) |
Locate Bio Ltd. |
United Kingdom (GB) |
Quirmbach, Michael (Corden Pharma 202112 CEO) |
Chief Executive Officer (CEO) |
Corden Pharma (CordenPharma) (Group) |
Germany |
Raab, Martin (Endress+Hauser 201604 Head Public + Internal Communication) |
Public Relations Manager / Investor Relations Manager |
Endress+Hauser (Group) |
Switzerland |
Raabe, Andreas (Adragos Pharma 202411 CEO + Founder) |
Chief Executive Officer (CEO) |
Adragos Pharma (Group) |
Germany |
Raasch, Martin (Dynamic42 202306 Managing Director) |
Managing Director |
Dynamic42 GmbH |
Germany |
Rabbe, Anders (Isofol Medical AB 201502 Managing Director) |
Managing Director |
Isofol Medical AB |
Sweden |
Rabini, Johannes (Sobera Capital 2010– Managing Director + Co-Founder before Triginta Capital) |
Managing Director |
Sobera Capital GmbH |
Germany |
Rabinowitz, Matthew (Natera Inc 201302 CEO) |
Chief Executive Officer (CEO) |
Natera Inc. (Nasdaq: NTRA) |
United States (USA) |
Rabus, Werner W. |
n. a. |
Eisenführ Speiser Patentanwälte Rechtsanwälte PartGmbB |
Germany |
Racamier, Isabelle (EsoCap 202111 CEO) |
Chief Executive Officer (CEO) |
EsoCap AG |
Switzerland |
Rachel, Thomas (BMBF 200709 Staatssekretär) |
n. a. |
Germany (govt) |
Germany |
Radakovic, Stojan (Ako med d.o.o. 201310 Director) |
President/Director/Head Business Group/Unit/Division |
Ako med d.o.o. |
Serbia |
Rademacher, Christoph (Cutanos 202107 Co-Founder + Prof at University of Vienna) |
Company Founder |
Cutanos GmbH |
Austria |
Radic, Christofer (Nanohale 201111 IR + PR Manager) |
Public Relations Manager / Investor Relations Manager |
Formycon (Group) |
Germany |
Raditsch, Martin (Carma Fund 202206– General Partner + since 201701 CEO of Innovectis) |
General Partner (venture partner) |
University of Frankfurt (Goethe-Universität) |
Germany |
Radloff, Chris (Danaher 201508 Sciex VP + General Manager LC-MS Business before VP Applied Markets + Clinical Research) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
Radvanyi, Laszlo (Merck (DE) 201511– Head of Global Immuno-oncology Research before CSO at Lion Biotechnologies) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Merck (DE) (Group) |
Germany |
Radwan, Ashraf (Yas Holding 202211 CEO of GlobalOne Healthcare Holding) |
Chief Executive Officer (CEO) |
Yas Holding (Group) |
United Arab Emirates (UAE) |
Raem, Arnold Maria (Arrows Biomedical Deutschland GmbH 201408 Managing Director) |
Managing Director |
Arrows Biomedical (Group) |
Germany |
Raetzman, Stuart (Alcon 201101 VP Global Marketing + General Manager US Business) |
Sales Manager / Marketing Manager |
Novartis (Group) |
Switzerland |
Raffensperger, Alan (Sobi 201201– COO before Benechill + Amgen + Roche + Boehringer Mannheim + Pharmacia) |
Chief Operating Officer (COO) |
Swedish Orphan Biovitrum (Sobi) (Group) |
Sweden |
Rafigh, Mehran (Sartorius 201309 Business Development Manager before HTGF Investment Manager) |
Business Development Manager / Strategy Manager |
Sartorius (Group) |
Germany |
Ragab, Mohamed (iTeos Therapeutics 201706– VP Corp Development before BMS + Roche + Pfizer + Ortho Biotech) |
Business Development Manager / Strategy Manager |
iTeos Therapeutics (Group) |
Belgium |
Ragan, Paula (X4 Pharmaceuticals 201811 CEO) |
Chief Executive Officer (CEO) |
X4 Pharmaceuticals (Group) |
United States (USA) |
Ragnarsson, Birgir Már (Novator Partners 202205 Partner) |
Partner (venture partner) |
Novator Partners (Group) |
United Kingdom (GB) |
Ragotzky, Klaus (Fidura 202011 Managing Director + Chairman of Advisory Board) |
Managing Director |
Fidura Private Equity Fonds (Group) |
Germany |
Rajathurai, Arnold (Bayer Technology Systems 200503) |
n. a. |
Bayer (Group) |
Germany |
Rajewsky, Klaus (Harvard Univ 2002– before Univ Cologne) |
n. a. |
Harvard University |
United States (USA) |
Rajkomar, Iyona (KKR 202405 Managing Partner at Dawn Biopharma) |
Investment Manager |
KKR (Kohlberg Kravis Roberts) (Group) |
|
Rajmann, Britta |
n. a. |
Wiley (Group) |
Germany |
Ralser, Markus (Francis Crick Institute 201606 before Univ Cambridge 201310) |
mass spectrometry (MS) |
Francis Crick Institute Ltd., The |
United Kingdom (GB) |
Rama, Rachel (Bayer 202308 Head of Small Molecules at Bayer Crop Science) |
n. a. |
Bayer (Group) |
Germany |
Ramachandra, Murah (Aurigene 201306 SVP Preclinical Biology) |
Research & Development Manager |
Dr. Reddy’s (Group) |
India |
Raman, Prakash (Flagship Pioneering 201911– Senior Partner + Chief BusDev Officer before Novartis NIBR + AstraZeneca) |
Partner (venture partner) |
Flagship Pioneering |
United States (USA) |
Ramanayake, Thaminda (CureVac 202406– CBO before Affini-T Therapeutics + Sanofi + BioMarin + Amgen) |
Chief Business Officer (CBO) |
CureVac (Group) |
Germany |
Ramaswamy, Vivek (Roivant Sciences 201708 CEO + Founder) |
Chief Executive Officer (CEO) |
Roivant (Group) |
Switzerland |
Rambeaux, Eric (MyoPowers 210506 CEO) |
Chief Executive Officer (CEO) |
Affluent Medical (Group) |
France |
Ramdahl, Thomas (Algeta 201308– COO before CTO before CEO since 2001) |
Chief Operating Officer (COO) |
Bayer (Group) |
Norway |
Ramesh, R. (Medi Analytika India 201505 Managing Director) |
Managing Director |
Medi Analytika India Pvt. Ltd. |
India |
Ramos, Luis (HH2E 202206 Head of Communications) |
Public Relations Manager / Investor Relations Manager |
HH2E (Group) |
Germany |
Rampf, Stefan (Rentschler 201605–2020006 CFO before ABL Technik Entlackung GmbH + Volvo Financial Services LEFT 6/20) |
Chief Financial Officer (CFO) |
Rentschler (Group) |
Germany |
Ramroth, Michael (Biotest 201301 CFO) |
Chief Financial Officer (CFO) |
Grifols (Group) |
Germany |
Ramsay, John (Syngenta 200707– CFO) |
Chief Financial Officer (CFO) |
Syngenta (Group) |
Switzerland |
Rando, Jason (Tiberend Strategic Advisors 201707 EVP + COO) |
Chief Operating Officer (COO) |
Tiberend Strategic Advisors (NY) |
United States (USA) |
Rang, Harald (BASF 201707 SVP Global RnD Crop Protection) |
Research & Development Manager |
BASF (Group) |
Germany |
Rant, Ulrich (Dynamic Biosensors GmbH 201301 Managing Director (CEO) + Co-Founder) |
Chief Executive Officer (CEO) |
Bruker (Group) |
Germany |
Rao, Arvind (Rockwell 202406 Global VP Industry Solutions) |
President/Director/Head Business Group/Unit/Division |
Rockwell (Group) |
United States (USA) |
Rao, Venkat (Sartorius 201902 Head Business Management, EMEA Life Science Research) |
Business Development Manager / Strategy Manager |
Sartorius (Group) |
Germany |
Rapberger, Ronald (PrimeCrowd 202107 Chief Investment Officer) |
Investment Manager |
G8Way Ventures GmbH (Gateway Ventures) |
Austria |
Rapp, Stephan (Neuway Pharma GmbH 20140–201508 Managing Director) |
Managing Director |
Neuway Pharma GmbH |
Germany |
Rapp, Ulf R. (Universität Würzburg 200504) |
n. a. |
University of Würzburg |
Germany |
Rappuoli, Rino (GSK 202110 Head of Vaccines RnD) |
Research & Development Manager |
GSK (Group) |
United Kingdom (GB) |
Raquet, Line Stigen (Creoptix 202001– CEO before Mettler-Toledo + Qiagen) |
Chief Executive Officer (CEO) |
Spectris (Group) |
Switzerland |
Rasche, Michael (Diadem 202407– CEO before miDiagnostics + Metabolon + Definiens + Ayoxxa + Dako + Roche) |
Chief Commercial Officer (CCO) |
AstraZeneca (Group) |
Germany |
Rasche, Thom (Earlybird 200809 Partner) |
Partner (venture partner) |
Earlybird (Group) |
Germany |
Rascher-Eggstein, Gesa (Nanion Technologies 201607– Marketing Director before Anaxon + Axiogenesis + Cytocentrics) |
n. a. |
Nanion (Group) |
Germany |
Raschke, Eva |
n. a. |
Thermo Fisher (Group) |
Germany |
Raschke, Fabian (Grünenthal 201902– CFO joined 201609 before Xella Group) |
Chief Financial Officer (CFO) |
Grünenthal (Group) |
Germany |
Rasi, Guido (EMA 201111– Executive Director) |
Administrative Officer (personnel) |
EU (govt) |
Netherlands |
Rasmus, Conrad (Protembis GmbH 2013– Managing Director + Co-Founder) |
Managing Director |
Protembis GmbH |
Germany |
Rataj, Sue H. (Agilent 201509– Non-exec Board Member + Bayer 201204– Supervisory Board Member before BP retired 4/11) |
Board member, non-executive |
Agilent (Group) |
United States (USA) |
Rataul, Billoo (Paramit 202106 CEO + President) |
Chief Executive Officer (CEO) |
Tecan (Group) |
United States (USA) |
Ratcliffe, Andrew (Cellzome 200809– Director Chemistry before UCB Celltech) |
n. a. |
GSK (Group) |
United States (USA) |
Ratcliffe, Ian (Stemgent 201303 CEO) |
Chief Executive Officer (CEO) |
ReproCell (Group) |
United States (USA) |
Rathgeb, Frank (Sygnis Pharma 201109 CMO) |
Chief Medical Officer (CMO) |
2invest (Group) |
Germany |
Rathi, V. L. (Advanced Enzyme Technologies 201707 Chairman) |
Board member |
Advanced Enzyme Technologies (Advanced Enzymes) (Group) |
India |
Rathmann, Torsten (Werner Rathmann Maschinenbau GmbH 201106 Managing Director) |
Managing Director |
Werner Rathmann Maschinenbau GmbH |
Germany |
Raths, Jürgen (Paion 201509–201703 COO before Executive Insight + Correvio Intl + Arpida + Lilly LEFT 3/17) |
Chief Operating Officer (COO) |
Humanwell Healthcare (Group) |
Germany |
Rau, Norbert (Raucon 202102) |
Company Founder |
RauCon (Group) |
Germany |
Rauch, Jörg (Univ Heidelberg 201404 Managing Partner of Technology Transfer Heidelberg GmbH) |
Managing Director |
University of Heidelberg (Ruperto Carola) |
Germany |
Rauch, Peter (Candor Bioscience 201310 Managing Director) |
Managing Director |
Medix Biochemica (Group) |
Germany |
Raue, Jan Simon (Fosanis GmbH 201908 Managing Director + Co-Founder) |
Managing Director |
Fosanis GmbH |
Germany |
Raueiser, Thomas (Nordrhein-Westfalen (govt) 201106 Investment Manager at NRW.BANK) |
Investment Manager |
Nordrhein-Westfalen (govt region) |
Germany |
Rauen, Hans-Werner (Bayer 201501 Global Regulatory Affairs Manager Insecticides at Bayer CropScience) |
Regulatory Affairs Manager |
Bayer (Group) |
Germany |
Raupach, Georg (Bayer 201501 Global Product Manager Insecticides at Bayer CropScience) |
Product Manager (personnel) |
Bayer (Group) |
Germany |
Raupach, Stefan (Abviris 2014– Managing Director + Co-Founder) |
Managing Director |
Abviris Deutschland GmbH |
Germany |
Raupp, Nikolaus (Nik) (High-Tech Gründerfonds 202111 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
Rausch, Oliver (Storm Therapeutics 201702 VP R&D before Cellzome + UCB Celltech + GSK) |
Research & Development Manager |
Storm Therapeutics Ltd. |
United Kingdom (GB) |
Rausch, Sebastian (Berlin Capital Fund 200504 Senior Investment Manager) |
Investment Manager |
Triginta Capital (Group) |
Germany |
Rauschenbusch, Alex (Grazia Equity GmbH 201412 Managing Partner) |
Managing Partner (investment firm) |
Grazia Equity GmbH |
Germany |
Rautter, Joachim (Peppermint 2014 Managing Partner) |
Managing Partner |
Peppermint (Group) |
Germany |
Ravagnan, Luca (Wise Srl 202010 CEO) |
Chief Executive Officer (CEO) |
Wise (Group) |
Italy |
Ravens, Jens (Epigenomics 202304 CFO) |
Chief Financial Officer (CFO) |
Epigenomics (Group) |
Germany |
Ravina, Carlo Germano (Merloni 202410 Managing Director of NovaCapital) |
Managing Director |
Merloni (Group) |
|
Ravishankar, Hema (Evonik 200806 Business Director Pharma Polymer India) |
Business Development Manager / Strategy Manager |
Evonik (Group) |
Germany |
Ravnsborg, Christian (Evosep 202310– VP Marketing before CEO + Bruker Daltonics) |
Sales Manager / Marketing Manager |
Evosep ApS |
Denmark |
Raya, Michael (Hikma 201507 Managing Director of West-Ward) |
Managing Director |
Hikma (Group) |
United States (USA) |
Raybaud, Olivier (SWEN Capital Partners 202309 Managing Director) |
Managing Director |
SWEN Capital Partners (Group) |
|
Rayment, Cary (Alcon –200709– President, Chairman + CEO) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Switzerland |
Raymont, Michael (AVAC Ltd 201502 CEO) |
Chief Executive Officer (CEO) |
AVAC Ltd. |
Canada |
Raythatha, Jigar (Constellation 202106 CEO) |
Chief Executive Officer (CEO) |
Novartis (Group) |
United States (USA) |
Read, Julian (Simris 2023 CEO) |
Chief Executive Officer (CEO) |
Simris (Group) |
Sweden |
Read, Simon (Mariana Oncology 202405 CEO + Founder) |
Chief Executive Officer (CEO) |
Mariana Oncology Inc. |
United States (USA) |
Rebeaud, Fabien (Abionic 201909 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Abionic S.A. |
Switzerland |
Reckmann, Bernd (Merck KGaA 1986–201604 Executive Board Member since 2007 RETIRED 4/16)) |
Board member, executive |
Merck (DE) (Group) |
Germany |
Redant, Emile (Zymofix 202411 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Zymofix N.V. |
Belgium |
Reddy, David (Roche 200611 Influenza Pandemic Taksforce Leader) |
n. a. |
Roche (Group) |
Switzerland |
Reddy, Sai (deepCDR Biologics 202112 Founder + Associate Prof at ETH Zurich Dept of Biosystems Science + Engineering) |
Company Founder |
Alloy Therapeutics (Group) |
Switzerland |
Reddy, Venkat (Macrophage Pharma 202106– CEO joined 1/20 as CSO before Glenmark Pharma + Pfizer + Sanofi + Novartis) |
Chief Executive Officer (CEO) |
Macrophage Pharma Ltd. (MPL) |
United Kingdom (GB) |